Читать книгу Clinical Pharmacology and Therapeutics - Группа авторов - Страница 136

A 45‐year‐old man has recently been diagnosed with advanced cancer. He attends clinic to discuss treatment options and has brought with him several printouts from the Internet which he wants to ask you about. He has read that there is a new drug for his condition which has shown some promising early results in a Phase III clinical trial. The drug showed some modest survival benefits compared with current standard therapy, alongside relatively manageable side effects, and your patient would therefore like to be prescribed the drug. However, you know that this new medicine is very expensive and that it has recently had a health economic evaluation. The result is that it is not recommended for use for patients you look after. What tools are used by health economists to decide whether a drug offers value for money?